ES2080218T3 - Emulsion grasa. - Google Patents

Emulsion grasa.

Info

Publication number
ES2080218T3
ES2080218T3 ES91118627T ES91118627T ES2080218T3 ES 2080218 T3 ES2080218 T3 ES 2080218T3 ES 91118627 T ES91118627 T ES 91118627T ES 91118627 T ES91118627 T ES 91118627T ES 2080218 T3 ES2080218 T3 ES 2080218T3
Authority
ES
Spain
Prior art keywords
fat emulsion
anoxemic
arrhythmia
indene
syndromes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91118627T
Other languages
English (en)
Inventor
Tetsuro Kikuchi
Katsura Tottori
Shinichi Ishikawa
Yoshito Masuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Application granted granted Critical
Publication of ES2080218T3 publication Critical patent/ES2080218T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA EMULSION GRASA INCLUYE DERIVADOS DE 2, 3-DIHIDRO-1H-INDENE, REPRESENTADOS POR LA FORMULA GENERAL (1) COMO UN INGREDIENTE ACTIVO UN INGREDIENTE ACEITOSO, ACEPTADO FARMACEUTICAMENTE, Y AGUA. DICHA EMULSION GRASA ES UTIL, PARA EL MEJORAMIENTO DE LOS SINTOMAS Y SINDROMES ANOXEMICOS E HIPOXICOS Y DE IGUAL MANERA ES EFECTIVA COMO AGENTE PREVENTIVO DE LA ARRITMIA Y DEL ATAQUE AL CORAZON PROVOCADO POR UNA INSUFICIENCIA DE OXIGENO Y SIMILARES.
ES91118627T 1990-10-31 1991-10-31 Emulsion grasa. Expired - Lifetime ES2080218T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP29583290 1990-10-31

Publications (1)

Publication Number Publication Date
ES2080218T3 true ES2080218T3 (es) 1996-02-01

Family

ID=17825762

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91118627T Expired - Lifetime ES2080218T3 (es) 1990-10-31 1991-10-31 Emulsion grasa.

Country Status (9)

Country Link
US (1) US5506230A (es)
EP (1) EP0483854B1 (es)
JP (1) JPH089542B2 (es)
KR (1) KR100187652B1 (es)
AU (1) AU637267B2 (es)
DE (1) DE69113391T2 (es)
DK (1) DK0483854T3 (es)
ES (1) ES2080218T3 (es)
TW (1) TW203010B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7014864B1 (en) * 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
JP2007105138A (ja) 2005-10-12 2007-04-26 Brother Ind Ltd 刺繍枠及び刺繍縫製可能なミシン

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5670826A (en) * 1979-11-15 1981-06-13 Nippon Saafuakutanto Kogyo Kk Oil-in-polyhydric alcohol type emulsion composition
JPS59122423A (ja) * 1982-12-28 1984-07-14 Green Cross Corp:The 制癌剤含有脂肪乳剤
JPS6169747A (ja) * 1984-08-31 1986-04-10 Otsuka Pharmaceut Co Ltd ２，３―ジヒドロ―１ｈ―インデン誘導体及びその製造法
EP0173331B1 (en) * 1984-08-31 1991-08-14 Otsuka Pharmaceutical Co., Ltd. 2,3-dihydro-1h-indene derivatives, a process for preparing them and pharmaceutical compositions containing same
IL78929A0 (en) * 1985-07-29 1986-09-30 Abbott Lab Microemulsion compositions for parenteral administration
DE3623376A1 (de) * 1986-07-11 1988-01-21 Behringwerke Ag Pharmazeutische formulierung und verfahren zu deren herstellung
JPH01226807A (ja) * 1988-03-04 1989-09-11 Tsumura & Co 脂肪乳剤およびその製造方法
JPH0225418A (ja) * 1988-07-14 1990-01-26 Kyorin Pharmaceut Co Ltd イブジラスト脂肪乳剤およびその製造方法
JP2838164B2 (ja) * 1988-09-29 1998-12-16 株式会社資生堂 乳化組成物
JP2844756B2 (ja) * 1989-12-01 1999-01-06 日本新薬株式会社 脂肪乳剤
JP2834604B2 (ja) * 1991-07-12 1998-12-09 農林水産省草地試験場長 家畜用歩行通過型体重測定装置とこれを用いた家畜への体重データ記録方法

Also Published As

Publication number Publication date
EP0483854A1 (en) 1992-05-06
AU637267B2 (en) 1993-05-20
AU8685491A (en) 1992-05-07
JPH089542B2 (ja) 1996-01-31
KR100187652B1 (ko) 1999-06-01
DE69113391T2 (de) 1996-04-18
DK0483854T3 (da) 1996-01-29
EP0483854B1 (en) 1995-09-27
JPH0532549A (ja) 1993-02-09
KR920007628A (ko) 1992-05-27
DE69113391D1 (de) 1995-11-02
US5506230A (en) 1996-04-09
TW203010B (es) 1993-04-01

Similar Documents

Publication Publication Date Title
ES2060635T3 (es) Fenilglicinas para usar en la reduccion de la lesion neurotoxica.
CO4440476A1 (es) Composicion sinergistica que comprende una combinacion plaguicida de ingredientes activos .
ES2042528T3 (es) Un procedimiento de preparacion de una composicion para potenciar la penetracion por membranas de al menos un agente sistematicamente activo.
ES2068862T3 (es) Derivado de 3'-hidroxibenzoxazinorifamicina; procedimiento para la preparacion del mismo y agente antibacteriano que contiene el mismo.
NO842978L (no) Farmasoeytiske midler for behandling av diabetes
NO990916D0 (no) Bruk av GLP-1 eller analoger i behandlingen av myokardialt infarkt
DK341187A (da) Virucidt middel med bredspekret virkning
DE59400489D1 (de) Fungizide Wirkstoffkombinationen
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
BR9913932A (pt) Uso de análogos de glp-1 no tratamento de derrame
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
ES2094823T3 (es) Pasta dentifrica antimicrobiana.
ATE68348T1 (de) Pharmazeutische und kosmetische zusammensetzungen auf der basis von benzoylperoxid und lipophilen quaternaeren ammoniumsalizylaten und ihre verwendung, insbesondere bei der behandlung von akne.
ATE15596T1 (de) Pharmazeutische mittel.
AR019053A1 (es) Uso de 2'2'-difluoronucleosidos para la preparacion de un medicamento y composicion farmaceutica y producto farmaceutico que los contienen
ES2045189T3 (es) Nuevos agentes anti-arritmicos i.
ES2080218T3 (es) Emulsion grasa.
ES2179873T3 (es) Agente antiincrustante marino.
DK178188A (da) Antivirusmiddel
AR012039A1 (es) Utilizacion de derivados de benzofurano con actividad antiarritmica o de una de sus sales farmaceuticamente aceptables como principios activos para lapreparacion de composiciones farmaceuticas
ES2039719T3 (es) Procedimiento para preparar un agente terapeutico para el tratamiento de la enfermedad de ulcera peptica.
CO4230094A1 (es) Composiciones
SE7701441L (sv) Nytt piperazinyluracilsalt
ES2038154T3 (es) Un procedimiento para preparar una composicion para potenciar la penetracion de membranas de al menos un agente sistematicamente activo.
KR890001540A (ko) 심부전증 치료제

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 483854

Country of ref document: ES